22 COVID-19 vaccines enter clinical trials in China: health official
Xinhua |
Updated: 2021-07-08 19:36
Share
Share - WeChat
BEIJING - Twenty-two COVID-19 vaccines have been approved to enter clinical trials in China, a health official said Thursday.
To date, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, said Yuan Lin, an official with the National Medical Products Administration (NMPA), at a press conference in Beijing.
By the end of June, the NMPA had granted emergency approval for clinical trials to 25 drugs intended for the treatment of COVID-19 and its indications, Yuan added.
- 102-year-old veteran recalls war, hails China's rise
- China enhancing childcare services with eye on fertility rate
- Monkeys thriving at a research base in Hubei
- Youth exchange fosters cross-cultural friendships
- China expels Japanese vessel for illegally entering waters
- Explore Tianjin: Is everyone here so optimistic?
